| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |